ライフサイエンスコーパス: transplant evaluation

1 part be ameliorated by earlier referral for transplant evaluation.

2 and nucleic acid testing obtained during the transplant evaluation.

3 006, 202 patients with HCC were referred for transplant evaluation.

4 ersity center for clinical management and/or transplant evaluation.

5 ssions regarding patients referred for heart transplant evaluation.

6 ly liver dysfunction indicating the need for transplant evaluation.

7 eu that needs to be addressed is part of the transplant evaluation.

8 pients (156/645) were smokers at the time of transplant evaluation.

9 tly higher for those who quit smoking before transplant evaluation.

10 alence of ACKD and renal cancer during renal transplant evaluation.

11 108 consecutive patients referred for heart transplant evaluation, 80 were placed on a waiting list,

12 rrected iothalamate clearance at the time of transplant evaluation and 1 year posttransplant and also

13 hone interviews (shortly after initiation of transplant evaluation and after being accepted or found

14 Hispanic patients initiating transplant evaluation and their family/friends at 2 tran

15 unctional class are not usually referred for transplant evaluations, as they are considered to be at

16 Kidney transplant candidates undergoing transplant evaluation at 2 transplant centers were rando

17 f patients referred and scheduled for kidney transplant evaluation at a single center from November 2

18 Adult patients referred for renal transplant evaluation at a single transplant center in t

19 ysis typically require a referral for kidney transplant evaluation at a transplant center from a dial

20 ample of 82 HF patients referred for cardiac transplant evaluation at an academic medical center duri

21 - 10 years old (mean +/- SD) who underwent a transplant evaluation at Columbia Presbyterian Medical C

22 ated using the Cockcroft-Gault method at the transplant evaluation; at the day of transplantation; an

23 tiorgan injury, and allow time to complete a transplant evaluation before long-term circulatory suppo

24 years in all children supports the role for transplant evaluation before treatment failure.

25 ient registry who underwent their first lung transplant evaluation between 2001 and 2009.

26 eated with dialysis were referred for kidney transplant evaluation between 2005 and 2011, but there w

27 e renal disease patients referred for kidney transplant evaluation between November 1991 and February

28 alcoholic cirrhosis were referred for liver transplant evaluation between September 1996 and May 199

29 >/=18 years of age undergoing primary renal transplant evaluation during a 10-year period.

30 Some patients referred for kidney transplant evaluation fail to attend the visit.

31 oidosis and heart failure referred for heart transplant evaluation from 1997 to 2004 were included in

32 ive study of 1,597 subjects undergoing renal transplant evaluation from June 1, 2006, to March 31, 20

33 50 years of age and over who underwent lung transplant evaluations from 1996 to 1999.

34 omic variables was made at the time of renal transplant evaluation in 450 consecutive candidates, 128

35 ncrease referral of patients on dialysis for transplant evaluation in the Reducing Disparities in Acc

36 thesize that decreased LVEF at time of renal transplant evaluation is an independent risk factor for

37 plant survival and is best incorporated into transplant evaluations on a continuous basis given limit

38 of previous alcoholic rehabilitation before transplant evaluation, P=0.001; and (V) failure to accep

39 nce patients' ability to complete the kidney transplant evaluation process.

40 atively recent addition of the HCT-CI to the transplant evaluation process.

41 arities were observed in access to referral, transplant evaluation, waitlisting and organ receipt.

42 Survival at 1-year after heart transplant evaluation was higher among transplanted pati

43 ociated with rate of completion of the renal transplant evaluation were analyzed using a retrospectiv

44 epted guidelines, many patients referred for transplant evaluation were not considered eligible for t

45 ECGs at pre-transplant evaluation were reviewed using the Minnesota

46 (GFR), assessed by Cr-EDTA clearance at pre-transplant evaluation, were retrospectively enrolled (n=

47 Referral for kidney transplant evaluation within 1 year of starting dialysis